Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;88(3):105131.
doi: 10.1016/j.jbspin.2021.105131. Epub 2021 Jan 21.

COVID-19 epidemiology in rheumatic diseases in Tuscany: A case-control study

Affiliations

COVID-19 epidemiology in rheumatic diseases in Tuscany: A case-control study

Paolo Francesconi et al. Joint Bone Spine. 2021 May.
No abstract available

Keywords: B-DMARDs; COVID-19; Rheumatic disease.

PubMed Disclaimer

References

    1. Tuscany region. 2020. Ticket payment exemptions for chronic diseases. [www.regione.toscana.it 15-exemptions-for-pathology-or-disability]
    1. Monti S., Balduzzi S., Delvino P., et al. Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies. Ann Rheum Dis. 2020;79:667–668. - PMC - PubMed
    1. Favalli E.G., Ingegnoli F., Cimaz R., et al. What is the true incidence of COVID-19 in patients with rheumatic diseases? Ann Rheum Dis. 2021;80:e18. - PubMed
    1. Conticini E., Bargagli E., Bardelli M., et al. COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic anti-rheumatic drugs. Ann Rheum Dis. 2020;80:e14. - PubMed
    1. Benucci M., Damiani A., Giannasi G., et al. Serological tests confirm the low incidence of COVID-19 in chronic rheumatic inflammatory diseases treated with biological DMARD. Ann Rheum Dis. 2020 doi: 10.1136/annrheumdis-2020-218214. - DOI - PubMed

Substances